[Recent Progress in Novel Therapies for Non-Muscle Invasive Bladder Cancer].
Non-muscle invasive bladder cancer(NMIBC)accounts for about 70% of bladder cancers, with most patients treated by TURBT followed by intravesical therapy according to recurrence risk.BCG is effective b
APA
Kawahara T (2026). [Recent Progress in Novel Therapies for Non-Muscle Invasive Bladder Cancer].. Gan to kagaku ryoho. Cancer & chemotherapy, 53(1), 7-9.
MLA
Kawahara T. "[Recent Progress in Novel Therapies for Non-Muscle Invasive Bladder Cancer].." Gan to kagaku ryoho. Cancer & chemotherapy, vol. 53, no. 1, 2026, pp. 7-9.
PMID
41555168
Abstract
Non-muscle invasive bladder cancer(NMIBC)accounts for about 70% of bladder cancers, with most patients treated by TURBT followed by intravesical therapy according to recurrence risk.BCG is effective but BCG-unresponsive cases often require cystectomy.Recently, novel therapies including immune checkpoint inhibitors, drug-delivery devices, and gene therapy have emerged.This chapter reviews recent and ongoing phase Ⅲ trials in BCG-naïve NMIBC.
MeSH Terms
Humans; Urinary Bladder Neoplasms; Neoplasm Invasiveness; Non-Muscle Invasive Bladder Neoplasms
같은 제1저자의 인용 많은 논문 (5)
- Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.
- Illustrating Implications of Misaligned Causal Questions and Statistics in Settings With Competing Events and Interest in Treatment Mechanisms.
- Patients' Preferences and the Time to Finish Gonadotropin-Releasing Hormone (GnRH) Agonist and Antagonist Injections in Japanese Prostate Cancer Patients.
- Re: Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study.
- Cerebral Infarction by Paradoxical Gas Embolism During Laparoscopic Liver Resection with Injury of the Hepatic Vessels in a Patient without a Right-to-Left Systemic Shunt.